vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and StepStone Group Inc. (STEP). Click either name above to swap in a different company.
StepStone Group Inc. is the larger business by last-quarter revenue ($586.5M vs $493.8M, roughly 1.2× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -21.0%, a 27.9% gap on every dollar of revenue. On growth, StepStone Group Inc. posted the faster year-over-year revenue change (73.0% vs -1.7%). Over the past eight quarters, StepStone Group Inc.'s revenue compounded faster (28.2% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Rosetta Stone Inc. is an American education technology software company that develops language, literacy and brain-fitness software. Best known for its language-learning products, in 2013, the company expanded beyond language into education-technology with its acquisitions of Livemocha, Lexia Learning, Fit Brains, and Tell Me More. In 2021, it became a subsidiary of IXL Learning.
MD vs STEP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $586.5M |
| Net Profit | $33.7M | $-123.5M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | -33.2% |
| Net Margin | 6.8% | -21.0% |
| Revenue YoY | -1.7% | 73.0% |
| Net Profit YoY | 10.5% | 35.7% |
| EPS (diluted) | $0.40 | $-1.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $586.5M | ||
| Q3 25 | $492.9M | $454.2M | ||
| Q2 25 | $468.8M | $364.3M | ||
| Q1 25 | $458.4M | $377.7M | ||
| Q4 24 | $502.4M | $339.0M | ||
| Q3 24 | $511.2M | $271.7M | ||
| Q2 24 | $504.3M | $186.4M | ||
| Q1 24 | $495.1M | $356.8M |
| Q4 25 | $33.7M | $-123.5M | ||
| Q3 25 | $71.7M | $-366.1M | ||
| Q2 25 | $39.3M | $-38.4M | ||
| Q1 25 | $20.7M | $-18.5M | ||
| Q4 24 | $30.5M | $-192.0M | ||
| Q3 24 | $19.4M | $17.6M | ||
| Q2 24 | $-153.0M | $13.3M | ||
| Q1 24 | $4.0M | $30.8M |
| Q4 25 | 9.9% | -33.2% | ||
| Q3 25 | 13.8% | -148.8% | ||
| Q2 25 | 12.8% | -5.6% | ||
| Q1 25 | 7.0% | 2.6% | ||
| Q4 24 | 7.8% | -101.7% | ||
| Q3 24 | 6.6% | 21.3% | ||
| Q2 24 | -31.3% | 29.4% | ||
| Q1 24 | 3.2% | 26.5% |
| Q4 25 | 6.8% | -21.0% | ||
| Q3 25 | 14.5% | -80.6% | ||
| Q2 25 | 8.4% | -10.5% | ||
| Q1 25 | 4.5% | -4.9% | ||
| Q4 24 | 6.1% | -56.6% | ||
| Q3 24 | 3.8% | 6.5% | ||
| Q2 24 | -30.3% | 7.2% | ||
| Q1 24 | 0.8% | 8.6% |
| Q4 25 | $0.40 | $-1.55 | ||
| Q3 25 | $0.84 | $-4.66 | ||
| Q2 25 | $0.46 | $-0.49 | ||
| Q1 25 | $0.24 | $-0.37 | ||
| Q4 24 | $0.37 | $-2.61 | ||
| Q3 24 | $0.23 | $0.26 | ||
| Q2 24 | $-1.84 | $0.20 | ||
| Q1 24 | $0.05 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | — |
| Total DebtLower is stronger | $570.5M | $270.2M |
| Stockholders' EquityBook value | $865.9M | $-378.8M |
| Total Assets | $2.2B | $5.2B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | — | ||
| Q3 25 | $340.1M | — | ||
| Q2 25 | $224.7M | — | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | — | ||
| Q2 24 | $19.4M | — | ||
| Q1 24 | $8.0M | — |
| Q4 25 | $570.5M | $270.2M | ||
| Q3 25 | $577.2M | $269.9M | ||
| Q2 25 | $583.9M | $269.6M | ||
| Q1 25 | $590.5M | $269.3M | ||
| Q4 24 | $597.1M | $168.9M | ||
| Q3 24 | — | $172.3M | ||
| Q2 24 | — | $172.1M | ||
| Q1 24 | — | $148.8M |
| Q4 25 | $865.9M | $-378.8M | ||
| Q3 25 | $890.7M | $-233.5M | ||
| Q2 25 | $833.8M | $153.9M | ||
| Q1 25 | $789.2M | $179.4M | ||
| Q4 24 | $764.9M | $209.8M | ||
| Q3 24 | $732.5M | $397.5M | ||
| Q2 24 | $706.5M | $366.9M | ||
| Q1 24 | $856.2M | $324.5M |
| Q4 25 | $2.2B | $5.2B | ||
| Q3 25 | $2.2B | $5.3B | ||
| Q2 25 | $2.1B | $4.8B | ||
| Q1 25 | $2.0B | $4.6B | ||
| Q4 24 | $2.2B | $4.3B | ||
| Q3 24 | $2.1B | $4.0B | ||
| Q2 24 | $2.0B | $3.8B | ||
| Q1 24 | $2.2B | $3.8B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | 1.75× | ||
| Q1 25 | 0.75× | 1.50× | ||
| Q4 24 | 0.78× | 0.81× | ||
| Q3 24 | — | 0.43× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.46× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $27.2M |
| Free Cash FlowOCF − Capex | — | $26.7M |
| FCF MarginFCF / Revenue | — | 4.6% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $18.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $27.2M | ||
| Q3 25 | $137.3M | $16.2M | ||
| Q2 25 | $137.2M | $46.3M | ||
| Q1 25 | $-117.5M | $-66.5M | ||
| Q4 24 | $133.0M | $27.6M | ||
| Q3 24 | $91.8M | $53.7M | ||
| Q2 24 | $107.0M | $50.2M | ||
| Q1 24 | $-125.2M | $7.6M |
| Q4 25 | — | $26.7M | ||
| Q3 25 | — | $15.9M | ||
| Q2 25 | — | $45.2M | ||
| Q1 25 | — | $-69.2M | ||
| Q4 24 | — | $27.0M | ||
| Q3 24 | — | $52.4M | ||
| Q2 24 | — | $49.6M | ||
| Q1 24 | — | $6.7M |
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 3.5% | ||
| Q2 25 | — | 12.4% | ||
| Q1 25 | — | -18.3% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | — | 19.3% | ||
| Q2 24 | — | 26.6% | ||
| Q1 24 | — | 1.9% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | 3.05× | ||
| Q2 24 | — | 3.76× | ||
| Q1 24 | -31.03× | 0.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
STEP
| Other | $210.1M | 36% |
| Management And Advisory Fees Net Focused Commingled Funds | $143.3M | 24% |
| Carried Interest Allocation Focused Commingled Funds | $85.1M | 15% |
| Carried Interest Allocation Separately Managed Accounts | $63.6M | 11% |
| Carried Interest Allocation Realized | $46.7M | 8% |
| Management And Advisory Fees Net Advisory And Other Services | $18.3M | 3% |
| Legacy Carried Interest Allocation Focused Commingled Funds | $10.3M | 2% |
| Income Based Incentive Fees | $6.0M | 1% |
| Management And Advisory Fees Net Fund Reimbursement Revenues | $3.1M | 1% |
